There are 2137 resources available
651P - Impact of abiraterone acetate plus prednisone (AAP) in patients with castration-sensitive prostate cancer (mCSPC) and visceral metastases: Subgroup analyses of the LATITUDE study
Presenter: Giulia Baciarello
Session: E-Poster Display
Resources:
Abstract
652P - Comparison of current systemic combination therapies for metastatic hormone-sensitive prostate cancer and selection of candidates for optimal treatment: A systematic review and Bayesian network meta-analysis
Presenter: Junru Chen
Session: E-Poster Display
Resources:
Abstract
653P - Features of molecular profile of prostate cancer after neoadjuvant treatment
Presenter: Mary Berkut
Session: E-Poster Display
Resources:
Abstract
654P - Real-world treatment (Tx) patterns in patients (Pts) with metastatic castration-resistant prostate cancer (mCRPC) and homologous recombination repair mutations (HRRm+)
Presenter: Neal Shore
Session: E-Poster Display
Resources:
Abstract
655P - Prognostic significance of docetaxel (D) plus androgen-deprivation therapy (ADT) in patients (p) with metastatic castration-sensitive prostate cancer (mCSPC) according to extent of disease: A study of real-world data
Presenter: Lucía Notario
Session: E-Poster Display
Resources:
Abstract
656P - Divergent results between Advanced Prostate Cancer Consensus Conference (APCCC) panelist (P) and global non-panelist (NP) survey respondents
Presenter: Charles Ryan
Session: E-Poster Display
Resources:
Abstract
657P - Mutation landscape of genes involved in DNA-damage repair pathway among Chinese patients with prostate cancer
Presenter: Jianguang Qiu
Session: E-Poster Display
Resources:
Abstract
658P - Impact of a mutation in HSD3B1 gene on the effectiveness of androgenic deprivation treatment in prostate cancer
Presenter: Carla Martín-Abreu
Session: E-Poster Display
Resources:
Abstract
659P - Rucaparib population pharmacokinetics (PPK) and exposure-response (ER) analyses in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC) in TRITON2
Presenter: Simon Chowdhury
Session: E-Poster Display
Resources:
Abstract
660P - Sequencing after taxane in patients with metastatic castration-resistant prostate cancer (mCRPC)
Presenter: Marina Mencinger
Session: E-Poster Display
Resources:
Abstract